SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+7.43%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$250M
AUM Growth
+$250M
(+7.6%)
Cap. Flow
-$6.96M
Cap. Flow
% of AUM
-2.78%
Top 10 Holdings %
Top 10 Hldgs %
38.88%
Holding
48
New
7
Increased
15
Reduced
15
Closed
5
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$4.16M |
| 2 |
Becton Dickinson
BDX
|
$3.96M |
| 3 |
Encompass Health
EHC
|
$3.05M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$3.04M |
| 5 |
Charles River Laboratories
CRL
|
$2.73M |
Top Sells
| 1 |
AbbVie
ABBV
|
$6.38M |
| 2 |
Agilent Technologies
A
|
$5.53M |
| 3 |
Waters Corp
WAT
|
$4.64M |
| 4 |
UnitedHealth
UNH
|
$3.6M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.24M |
Sector Composition
| 1 | Healthcare | 91.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $20.8M | 4.87% | 250,000 +50,000 | +25% | +$4.16M |
|
2
Tenet Healthcare
THC
$16.3B
| $11.4M | 2.66% | 140,000 -10,000 | -7% | -$814K |
|
3
Boston Scientific
BSX
$156B
| $8.65M | 2.02% | 160,000 +5,000 | +3% | +$270K |
|
4
Universal Health Services
UHS
$11.6B
| $8.28M | 1.94% | 52,500 -2,490 | -5% | -$393K |
|
5
Eli Lilly
LLY
$657B
| $8.21M | 1.92% | 17,500 -2,500 | -13% | -$1.17M |
|
6
Novo Nordisk
NVO
$251B
| $8.09M | 1.89% | 50,000 -10,000 | -17% | -$1.62M |
|
7
Cardinal Health
CAH
$35.5B
| $8.04M | 1.88% | 85,000 +5,000 | +6% | +$473K |
|
8
Zimmer Biomet
ZBH
$21B
| $8.01M | 1.87% | 55,000 -5,000 | -8% | -$728K |
|
|
9
Becton Dickinson
BDX
$55.3B
| $7.92M | 1.85% | 30,000 +15,000 | +100% | +$3.96M |
|
10
Surgery Partners
SGRY
$2.91B
| $7.87M | 1.84% | 175,000 | – | – |
|
11
Humana
HUM
$36.5B
| $7.83M | 1.83% | 17,500 -5,000 | -22% | -$2.24M |
|
12
Cencora
COR
$56.5B
| $7.7M | 1.8% | 40,000 | – | – |
|
13
Intuitive Surgical
ISRG
$170B
| $7.69M | 1.8% | 22,500 -7,500 | -25% | -$2.56M |
|
14
Stryker
SYK
$150B
| $7.63M | 1.78% | 25,000 | – | – |
|
15
HCA Healthcare
HCA
$94.5B
| $7.59M | 1.77% | 25,000 -5,000 | -17% | -$1.52M |
|
16
McKesson
MCK
$85.4B
| $7.48M | 1.75% | 17,500 +2,500 | +17% | +$1.07M |
|
17
Baxter International
BAX
$12.7B
| $7.29M | 1.71% | 160,000 +10,000 | +7% | +$456K |
|
|
18
Encompass Health
EHC
$12.3B
| $6.77M | 1.58% | 99,976 +44,976 | +82% | +$3.05M |
|
19
Elevance Health
ELV
$71.8B
| $6.66M | 1.56% | 15,000 +4,457 | +42% | +$1.98M |
|
20
Abbott
ABT
$231B
| $6.54M | 1.53% | 60,000 +15,000 | +33% | +$1.64M |
|
21
IQVIA
IQV
$32.4B
| $6.18M | 1.45% | 27,500 +7,500 | +38% | +$1.69M |
|
22
Select Medical
SEM
$1.61B
| $6.05M | 1.42% | 190,000 +82,162 | +76% | +$2.62M |
|
23
Danaher
DHR
$147B
| $6M | 1.4% | 25,000 +5,000 | +25% | +$1.2M |
|
24
Merck
MRK
$210B
| $5.77M | 1.35% | 50,000 -25,000 | -33% | -$2.89M |
|
25
Cigna
CI
$80.3B
| $5.61M | 1.31% | 20,000 +5,000 | +33% | +$1.4M |
|